Filter News
Area of Research
News Type
News Topics
- (-) Biomedical (2)
- (-) Security (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (3)
- Biology (2)
- Chemical Sciences (1)
- Computer Science (6)
- Coronavirus (2)
- Cybersecurity (3)
- Environment (1)
- Fusion (1)
- High-Performance Computing (1)
- Materials (3)
- Materials Science (5)
- Microscopy (1)
- Nanotechnology (2)
- National Security (4)
- Neutron Science (14)
- Physics (1)
- Quantum Computing (1)
- Quantum Science (3)
- Space Exploration (1)
- Transportation (1)
Media Contacts
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Deborah Frincke, one of the nation’s preeminent computer scientists and cybersecurity experts, serves as associate laboratory director of ORNL’s National Security Science Directorate. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.